LACK OF PHARMACOKINETIC INTERACTIONS BETWEEN MOXONIDINE AND DIGOXIN

被引：6
|
作者：
PABST, G
WEIMANN, HJ
WEBER, W
机构：
[1] KALI CHEM PHARMA GMBH, POB 220, W-3000 HANNOVER 1, GERMANY
[2] LAB GMBH & CO, NEU ULM, GERMANY
来源：
CLINICAL PHARMACOKINETICS | 1992年 / 23卷 / 06期
关键词：
D O I：
10.2165/00003088-199223060-00007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The potential for pharmacokinetic interactions between moxonidine and digoxin at steady-state was investigated in 15 healthy male volunteers. Multiple oral doses of 0.2mg moxonidine twice daily and 0.2mg digoxin once daily were administered alone and in combination in a randomised 3-period crossover design. The drugs were administered for at least 5 days. The results indicate that neither moxonidine nor digoxin influences the pharmacokinetics of the other drug under steady-state conditions.
引用
收藏
页码：477 / 481
页数：5
相关论文
共 50 条
  • [31] Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa
    Braun, Marina
    Cawello, Willi
    Andreas, Jens-Otto
    Boekens, Hilmar
    Horstmann, Rolf
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1047 - 1055
  • [32] Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers
    Murdoch, RD
    Zussman, B
    Schofield, JP
    Webber, DM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (09): : 1046 - 1053
  • [33] Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers
    Dockens, RC
    Greene, DS
    Barbhaiya, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (02): : 160 - 167
  • [34] Lack of pharmacokinetic interaction between valsartan, an angiotensin II receptor blocker, and digoxin, a cardiotonic agent.
    Prasad, P
    Mangat, S
    Yeh, CM
    Glazer, R
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 124A - 124A
  • [35] Absence of a pharmacokinetic interaction between digoxin and levofloxacin
    Chien, SC
    Rogge, MC
    Williams, RR
    Natarajan, J
    Wong, F
    Chow, AT
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (01) : 7 - 12
  • [36] Evaluation of a pharmacokinetic interaction between eszopiclone and digoxin
    Caron, J
    Wessel, T
    Maier, G
    SLEEP, 2004, 27 : 55 - 56
  • [37] Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers
    Ragueneau, I
    Poirier, JM
    Radembino, N
    Sao, AB
    Funck-Brentano, C
    Jaillon, P
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (03) : 453 - 456
  • [38] Lack of kinetic interaction between digoxin and voglibose
    Kusumoto, M
    Ueno, K
    Fujimura, Y
    Kameda, T
    Mashimo, K
    Takeda, K
    Tatami, R
    Shibakawa, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (01) : 79 - 80
  • [39] Lack of kinetic interaction between digoxin and voglibose
    M. Kusumoto
    K. Ueno
    Y. Fujimura
    T. Kameda
    K. Mashimo
    K. Takeda
    R. Tatami
    M. Shibakawa
    European Journal of Clinical Pharmacology, 1999, 55 : 79 - 80
  • [40] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 761 - 769
12345